###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 16/06/2016 14:20:57 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023052	signaling	1	9.66	2.04e-16	6.82e-14	41|63|648|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00090;PF00129;PF00135;PF00320;PF00520;PF00613;PF00683;PF00870;PF00907;PF00930;PF00969;PF01007;PF01094;PF01153;PF01421;PF01833;PF02191;PF02192;PF02931;PF03098;PF03508;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF08266;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0007154	cell communication	1	9.50	2.68e-16	6.82e-14	42|63|691|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00090;PF00129;PF00135;PF00320;PF00520;PF00613;PF00683;PF00870;PF00907;PF00930;PF00969;PF01007;PF01094;PF01153;PF01421;PF01833;PF02191;PF02192;PF02931;PF03098;PF03508;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF08266;PF10409;PF12031;PF13306;PF13465;PF13895;PF13927
Group	GO:0007399	nervous system development	1	10.02	4.66e-15	7.91e-13	32|63|397|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00090;PF00135;PF00320;PF00520;PF00870;PF00907;PF01049;PF01094;PF01153;PF01421;PF01833;PF02931;PF03508;PF05110;PF05923;PF07645;PF07679;PF07686;PF07710;PF07714;PF08266;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0048583	regulation of response to stimulus	1	9.46	1.10e-14	1.40e-12	35|63|503|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00129;PF00135;PF00320;PF00520;PF00683;PF00870;PF00969;PF01094;PF01153;PF01421;PF01833;PF02760;PF02931;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF09422;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0051239	regulation of multicellular organismal process	1	9.54	2.01e-14	2.05e-12	33|63|448|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00125;PF00135;PF00320;PF00520;PF00530;PF00870;PF00907;PF00969;PF01007;PF01049;PF01094;PF01833;PF02931;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0050793	regulation of developmental process	1	9.48	7.00e-14	5.94e-12	31|63|405|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00125;PF00135;PF00320;PF00520;PF00530;PF00870;PF00907;PF01049;PF01094;PF01833;PF02931;PF05902;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0010646	regulation of cell communication	1	9.52	2.51e-13	1.60e-11	28|63|336|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00135;PF00320;PF00520;PF00683;PF00870;PF00969;PF01094;PF01153;PF01833;PF02931;PF05923;PF07645;PF07654;PF07679;PF07710;PF07714;PF09422;PF10409;PF13465;PF13895;PF13927
Group	GO:0065008	regulation of biological quality	1	8.57	2.50e-13	1.60e-11	37|63|628|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00135;PF00201;PF00320;PF00520;PF00530;PF00613;PF00683;PF00685;PF00743;PF00870;PF00930;PF01007;PF01094;PF01421;PF02192;PF02931;PF03098;PF05110;PF05902;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0042221	response to chemical stimulus	1	8.38	8.70e-13	4.92e-11	36|63|615|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00129;PF00135;PF00201;PF00320;PF00413;PF00520;PF00613;PF00685;PF00743;PF00777;PF00870;PF00969;PF01094;PF01833;PF02760;PF02931;PF03098;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0051674	localization of cell	1	9.75	1.52e-12	6.80e-11	23|63|229|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00084;PF00320;PF00413;PF00520;PF00530;PF00907;PF00930;PF01049;PF01833;PF05923;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0002376	immune system process	1	9.13	1.74e-12	6.80e-11	27|63|334|3527	PF00001;PF00041;PF00046;PF00071;PF00079;PF00084;PF00090;PF00129;PF00320;PF00613;PF00870;PF00907;PF00930;PF00969;PF02192;PF02931;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0040011	locomotion	1	8.97	3.10e-12	1.01e-10	27|63|342|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00084;PF00090;PF00320;PF00413;PF00520;PF00530;PF00613;PF00907;PF00930;PF01049;PF01153;PF01833;PF02931;PF05923;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0032879	regulation of localization	1	9.02	4.15e-12	1.24e-10	26|63|318|3527	PF00001;PF00041;PF00046;PF00071;PF00084;PF00090;PF00135;PF00320;PF00413;PF00520;PF00907;PF00930;PF00969;PF01094;PF01833;PF02931;PF05110;PF07645;PF07654;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0051128	regulation of cellular component organization	1	8.72	1.22e-11	2.97e-10	26|63|333|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00135;PF00320;PF00520;PF00870;PF00930;PF01094;PF01833;PF02931;PF05110;PF05902;PF05923;PF07645;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0023051	regulation of signaling	1	8.12	3.53e-11	6.90e-10	29|63|441|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00090;PF00135;PF00320;PF00520;PF00683;PF00870;PF00969;PF01094;PF01153;PF01833;PF02931;PF05923;PF07645;PF07654;PF07679;PF07710;PF07714;PF09422;PF10409;PF13465;PF13895;PF13927
Group	GO:0006928	cellular component movement	1	8.58	4.68e-11	8.34e-10	24|63|296|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00084;PF00320;PF00413;PF00520;PF00530;PF00613;PF00907;PF00930;PF01049;PF01833;PF05923;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0009790	embryo development	1	8.51	5.82e-11	9.88e-10	24|63|299|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00125;PF00320;PF00520;PF00870;PF00907;PF01049;PF03508;PF05110;PF05923;PF07645;PF07679;PF07686;PF07710;PF07714;PF08266;PF13306;PF13465;PF13895;PF13927
Group	GO:0048518	positive regulation of biological process	1	7.49	6.41e-11	1.02e-09	35|63|667|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00125;PF00129;PF00135;PF00320;PF00520;PF00530;PF00870;PF00907;PF00930;PF00969;PF01094;PF01153;PF01833;PF02931;PF03508;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF12157;PF13306;PF13465;PF13895;PF13927
Group	GO:0048519	negative regulation of biological process	1	7.35	1.18e-10	1.83e-09	35|63|681|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00090;PF00125;PF00320;PF00520;PF00530;PF00613;PF00683;PF00870;PF00907;PF00930;PF00969;PF01094;PF01153;PF01833;PF02931;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF09422;PF10409;PF13465;PF13895;PF13927
Group	GO:0051716	cellular response to stimulus	1	7.05	1.47e-10	2.08e-09	39|63|853|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00079;PF00090;PF00125;PF00129;PF00201;PF00320;PF00520;PF00613;PF00683;PF00685;PF00743;PF00777;PF00870;PF00969;PF01094;PF01153;PF01833;PF02191;PF02192;PF02760;PF02931;PF03098;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13306;PF13465;PF13895;PF13927
Group	GO:0009605	response to external stimulus	1	7.90	4.75e-10	6.20e-09	24|63|330|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00090;PF00320;PF00520;PF00613;PF00969;PF01094;PF01833;PF02931;PF05923;PF07645;PF07654;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0000003	reproduction	1	6.19	2.13e-07	1.19e-06	23|63|412|3527	PF00001;PF00028;PF00041;PF00046;PF00060;PF00071;PF00079;PF00084;PF00125;PF00135;PF00320;PF00413;PF00520;PF00870;PF01094;PF01421;PF02931;PF07679;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0000902	cell morphogenesis	1	6.40	3.89e-07	2.00e-06	18|63|265|3527	PF00028;PF00041;PF00046;PF00071;PF00090;PF00320;PF00520;PF00530;PF01049;PF01153;PF01833;PF05923;PF07645;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0006950	response to stress	1	5.50	6.81e-07	3.18e-06	30|63|709|3527	PF00001;PF00041;PF00060;PF00071;PF00079;PF00084;PF00125;PF00129;PF00320;PF00413;PF00520;PF00530;PF00870;PF00969;PF01094;PF01833;PF02192;PF02931;PF03098;PF03508;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13306;PF13895;PF13927
Group	GO:0030030	cell projection organization	1	6.29	7.00e-07	3.24e-06	17|63|246|3527	PF00028;PF00041;PF00046;PF00071;PF00090;PF00135;PF00520;PF01049;PF01153;PF01833;PF05923;PF07645;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0032990	cell part morphogenesis	1	6.04	2.42e-06	9.72e-06	15|63|210|3527	PF00028;PF00041;PF00046;PF00090;PF00520;PF01049;PF01153;PF01833;PF05923;PF07645;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0065009	regulation of molecular function	1	5.20	8.66e-06	2.84e-05	20|63|396|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00079;PF00090;PF00135;PF00320;PF00520;PF00870;PF01094;PF02931;PF05902;PF07645;PF07679;PF07714;PF08266;PF13895;PF13927
Group	GO:0031323	regulation of cellular metabolic process	1	4.58	1.72e-05	5.07e-05	31|63|867|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00079;PF00125;PF00320;PF00520;PF00530;PF00870;PF00907;PF01094;PF01833;PF02312;PF02931;PF05110;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF08266;PF12031;PF12157;PF13306;PF13465;PF13895;PF13927
Group	GO:0007163	establishment or maintenance of cell polarity	1	5.24	1.38e-04	2.69e-04	8|63|88|3527	PF00028;PF00041;PF00071;PF01049;PF05923;PF07679;PF07714;PF13895
Group	GO:0060255	regulation of macromolecule metabolic process	1	3.98	1.53e-04	2.95e-04	29|63|868|3527	PF00001;PF00041;PF00046;PF00071;PF00079;PF00084;PF00125;PF00320;PF00530;PF00870;PF00907;PF01833;PF02312;PF02931;PF03508;PF05110;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF12031;PF12157;PF13465;PF13895;PF13927
Group	GO:0033036	macromolecule localization	1	4.09	3.33e-04	5.66e-04	16|63|354|3527	PF00001;PF00041;PF00060;PF00071;PF00135;PF00520;PF00683;PF00870;PF04548;PF07645;PF07679;PF07710;PF07714;PF10409;PF13465;PF13895
Group	GO:0080090	regulation of primary metabolic process	1	3.73	3.54e-04	5.97e-04	28|63|861|3527	PF00001;PF00041;PF00046;PF00071;PF00079;PF00084;PF00125;PF00320;PF00530;PF00870;PF00907;PF01094;PF01833;PF02312;PF02931;PF05110;PF05923;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF12031;PF12157;PF13465;PF13895;PF13927
Group	GO:0009889	regulation of biosynthetic process	1	3.77	4.41e-04	7.00e-04	23|63|646|3527	PF00001;PF00046;PF00125;PF00320;PF00520;PF00530;PF00870;PF00907;PF01094;PF01833;PF02312;PF05110;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF12031;PF12157;PF13306;PF13465;PF13895
Group	GO:0051234	establishment of localization	1	3.35	1.26e-03	1.75e-03	25|63|785|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00084;PF00135;PF00320;PF00520;PF00613;PF00683;PF00870;PF01007;PF01094;PF01833;PF02931;PF04548;PF07645;PF07679;PF07686;PF07710;PF07714;PF13465;PF13895;PF13927
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	3.10	2.96e-03	3.76e-03	21|63|647|3527	PF00001;PF00041;PF00046;PF00071;PF00125;PF00320;PF00530;PF00870;PF00907;PF01094;PF01833;PF02312;PF05110;PF07645;PF07679;PF07710;PF07714;PF12031;PF12157;PF13465;PF13895
Group	GO:0051641	cellular localization	1	2.99	4.63e-03	5.58e-03	17|63|494|3527	PF00001;PF00041;PF00046;PF00071;PF00135;PF00520;PF00683;PF00870;PF02931;PF04548;PF07645;PF07679;PF07710;PF07714;PF13465;PF13895;PF13927
Group	GO:0006955	immune response	2	10.74	9.76e-13	4.97e-11	19|63|140|3527	PF00001;PF00041;PF00071;PF00079;PF00084;PF00090;PF00129;PF00320;PF00870;PF00969;PF07645;PF07654;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0016477	cell migration	2	10.09	1.71e-12	6.80e-11	21|63|185|3527	PF00001;PF00028;PF00041;PF00046;PF00071;PF00320;PF00413;PF00530;PF00907;PF00930;PF01049;PF01833;PF05923;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0055123	digestive system development	2	13.18	2.59e-12	9.42e-11	12|63|42|3527	PF00041;PF00046;PF00320;PF00870;PF00907;PF07679;PF07686;PF07710;PF07714;PF13465;PF13895;PF13927
Group	GO:0071310	cellular response to organic substance	2	9.53	3.19e-12	1.01e-10	23|63|237|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00129;PF00201;PF00320;PF00520;PF00613;PF00777;PF00969;PF01094;PF02760;PF03098;PF07654;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0050776	regulation of immune response	2	10.64	5.44e-12	1.54e-10	17|63|116|3527	PF00041;PF00079;PF00084;PF00090;PF00129;PF00320;PF00969;PF02760;PF07645;PF07654;PF07679;PF07686;PF07714;PF13306;PF13465;PF13895;PF13927
Group	GO:0008285	negative regulation of cell proliferation	2	10.89	6.35e-12	1.70e-10	16|63|100|3527	PF00046;PF00079;PF00320;PF00870;PF00907;PF00969;PF05923;PF07654;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:2000145	regulation of cell motility	2	10.63	1.19e-11	2.97e-10	16|63|104|3527	PF00001;PF00041;PF00046;PF00071;PF00084;PF00090;PF00320;PF00413;PF00907;PF01833;PF07645;PF07679;PF07714;PF10409;PF13895;PF13927
Group	GO:0002252	immune effector process	2	10.65	2.44e-11	5.64e-10	15|63|92|3527	PF00001;PF00041;PF00071;PF00084;PF00090;PF00870;PF00969;PF07645;PF07654;PF07679;PF07686;PF07714;PF10409;PF13895;PF13927
Group	GO:1901214	regulation of neuron death	2	11.81	3.29e-11	6.70e-10	12|63|51|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00520;PF00870;PF01094;PF07679;PF07710;PF07714;PF13927
Group	GO:0042391	regulation of membrane potential	2	10.90	3.19e-11	6.70e-10	14|63|78|3527	PF00041;PF00060;PF00135;PF00520;PF00930;PF01007;PF01094;PF01421;PF02931;PF07679;PF07686;PF07714;PF13465;PF13895
Group	GO:0051046	regulation of secretion	2	10.25	6.28e-11	1.02e-09	15|63|98|3527	PF00001;PF00046;PF00071;PF00320;PF00520;PF00969;PF01094;PF01833;PF02931;PF07654;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0034097	response to cytokine stimulus	2	10.62	1.36e-10	2.04e-09	13|63|71|3527	PF00001;PF00041;PF00079;PF00129;PF00777;PF00969;PF02760;PF03098;PF07654;PF07679;PF07714;PF13895;PF13927
Group	GO:0009968	negative regulation of signal transduction	2	9.17	1.40e-10	2.04e-09	18|63|162|3527	PF00001;PF00028;PF00041;PF00046;PF00079;PF00320;PF00683;PF00870;PF01153;PF01833;PF05923;PF07645;PF07679;PF07714;PF09422;PF10409;PF13465;PF13895
Group	GO:0045321	leukocyte activation	2	9.82	1.74e-10	2.40e-09	15|63|105|3527	PF00001;PF00041;PF00046;PF00129;PF00613;PF00870;PF02192;PF02931;PF07654;PF07679;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0030097	hemopoiesis	2	9.59	3.02e-10	4.05e-09	15|63|109|3527	PF00001;PF00041;PF00046;PF00071;PF00320;PF00870;PF07645;PF07654;PF07679;PF07686;PF07710;PF07714;PF13465;PF13895;PF13927
Group	GO:0050817	coagulation	2	10.34	5.71e-10	7.08e-09	12|63|64|3527	PF00001;PF00041;PF00071;PF00079;PF00084;PF00320;PF00520;PF07679;PF07686;PF07714;PF13895;PF13927
Group	GO:0010975	regulation of neuron projection development	2	10.34	5.71e-10	7.08e-09	12|63|64|3527	PF00041;PF00060;PF00135;PF01094;PF01833;PF02931;PF07679;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0007600	sensory perception	2	9.60	5.88e-10	7.12e-09	14|63|96|3527	PF00001;PF00028;PF00046;PF00060;PF00071;PF00520;PF00907;PF01094;PF02931;PF07679;PF07686;PF07714;PF13895;PF13927
Group	GO:0051241	negative regulation of multicellular organismal process	2	10.06	1.00e-09	1.18e-08	12|63|67|3527	PF00001;PF00041;PF00060;PF00079;PF00907;PF00969;PF01094;PF02931;PF07645;PF07654;PF10409;PF13465
Group	GO:0060485	mesenchyme development	2	10.06	2.33e-09	2.58e-08	11|63|57|3527	PF00001;PF00046;PF00320;PF00530;PF00907;PF01833;PF07645;PF07679;PF07714;PF13465;PF13895
Group	GO:0007610	behavior	2	8.35	3.73e-09	4.04e-08	16|63|151|3527	PF00001;PF00028;PF00046;PF00060;PF00071;PF00135;PF00520;PF00530;PF00907;PF01094;PF01421;PF02931;PF07714;PF13306;PF13895;PF13927
Group	GO:0007548	sex differentiation	2	9.39	3.91e-09	4.14e-08	12|63|75|3527	PF00041;PF00046;PF00125;PF00320;PF00870;PF01421;PF07679;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0051606	detection of stimulus	2	9.76	4.16e-09	4.32e-08	11|63|60|3527	PF00001;PF00028;PF00060;PF00520;PF00969;PF01094;PF07654;PF07679;PF07714;PF13895;PF13927
Group	GO:0002697	regulation of immune effector process	2	9.48	7.17e-09	7.16e-08	11|63|63|3527	PF00001;PF00041;PF00084;PF00129;PF07654;PF07686;PF07714;PF13306;PF13465;PF13895;PF13927
Group	GO:0016337	cell-cell adhesion	2	9.91	7.56e-09	7.40e-08	10|63|49|3527	PF00028;PF00041;PF00135;PF01049;PF07679;PF07686;PF07714;PF08266;PF13895;PF13927
Group	GO:0050865	regulation of cell activation	2	9.02	8.42e-09	8.08e-08	12|63|80|3527	PF00001;PF00041;PF00084;PF00320;PF00930;PF00969;PF07654;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0051240	positive regulation of multicellular organismal process	2	8.70	8.77e-09	8.26e-08	13|63|98|3527	PF00001;PF00046;PF00060;PF00079;PF00135;PF00320;PF00520;PF00907;PF01094;PF07645;PF07679;PF07714;PF13465
Group	GO:0043583	ear development	2	9.79	9.31e-09	8.47e-08	10|63|50|3527	PF00028;PF00046;PF00129;PF00320;PF00907;PF07645;PF07654;PF07679;PF07714;PF13895
Group	GO:0035556	intracellular signal transduction	2	7.84	9.26e-09	8.47e-08	17|63|184|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00320;PF00520;PF00613;PF00870;PF01094;PF07645;PF07679;PF07710;PF07714;PF10409;PF13895;PF13927
Group	GO:0002684	positive regulation of immune system process	2	8.41	9.55e-09	8.53e-08	14|63|118|3527	PF00001;PF00041;PF00084;PF00090;PF00129;PF00320;PF00930;PF00969;PF07645;PF07654;PF07686;PF07714;PF13465;PF13895
Group	GO:0050878	regulation of body fluid levels	2	8.89	1.13e-08	9.88e-08	12|63|82|3527	PF00001;PF00041;PF00079;PF00084;PF00320;PF00520;PF01094;PF07679;PF07686;PF07714;PF13895;PF13927
Group	GO:0060341	regulation of cellular localization	2	7.91	1.94e-08	1.67e-07	15|63|146|3527	PF00001;PF00046;PF00071;PF00320;PF00520;PF00969;PF01094;PF01833;PF02931;PF07654;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0048511	rhythmic process	2	9.25	2.47e-08	2.10e-07	10|63|55|3527	PF00001;PF00041;PF00320;PF00520;PF01421;PF02931;PF07679;PF07714;PF13895;PF13927
Group	GO:0071495	cellular response to endogenous stimulus	2	7.96	2.78e-08	2.32e-07	14|63|128|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00201;PF00320;PF00613;PF01094;PF07679;PF07714;PF10409;PF13465;PF13895
Group	GO:0032101	regulation of response to external stimulus	2	8.15	5.51e-08	4.45e-07	12|63|94|3527	PF00001;PF00041;PF00060;PF00079;PF00084;PF00320;PF01094;PF01421;PF01833;PF07679;PF07714;PF13895
Group	GO:0001654	eye development	2	7.88	5.69e-08	4.47e-07	13|63|114|3527	PF00028;PF00041;PF00046;PF00071;PF00520;PF01049;PF01153;PF05110;PF07679;PF07714;PF10409;PF13465;PF13895
Group	GO:0042981	regulation of apoptotic process	2	7.01	6.53e-08	5.03e-07	18|63|236|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00090;PF00320;PF00520;PF00613;PF00870;PF00907;PF01094;PF07679;PF07710;PF07714;PF10409;PF13895;PF13927
Group	GO:0007444	imaginal disc development	2	8.24	8.45e-08	6.12e-07	11|63|79|3527	PF00028;PF00041;PF00046;PF00135;PF00413;PF01833;PF07645;PF07679;PF07686;PF07714;PF13465
Group	GO:0045597	positive regulation of cell differentiation	2	7.93	8.87e-08	6.12e-07	12|63|98|3527	PF00001;PF00041;PF00046;PF00090;PF00320;PF00530;PF00907;PF07645;PF07679;PF07714;PF13465;PF13895
Group	GO:0044057	regulation of system process	2	7.70	8.65e-08	6.12e-07	13|63|118|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00135;PF00520;PF01007;PF01094;PF01833;PF02931;PF07679;PF07686
Group	GO:0030900	forebrain development	2	8.11	1.10e-07	7.19e-07	11|63|81|3527	PF00001;PF00041;PF00046;PF00060;PF01094;PF07645;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0048608	reproductive structure development	2	7.57	1.17e-07	7.46e-07	13|63|121|3527	PF00041;PF00046;PF00071;PF00125;PF00320;PF00870;PF01421;PF07679;PF07686;PF07714;PF13465;PF13895;PF13927
Group	GO:0006909	phagocytosis	2	8.82	1.21e-07	7.59e-07	9|63|49|3527	PF00041;PF00084;PF00320;PF07645;PF07679;PF07686;PF07714;PF13895;PF13927
Group	GO:0060541	respiratory system development	2	8.04	1.26e-07	7.70e-07	11|63|82|3527	PF00028;PF00041;PF00135;PF00320;PF00413;PF07645;PF07679;PF07714;PF10409;PF13465;PF13895
Group	GO:0031347	regulation of defense response	2	7.77	1.25e-07	7.70e-07	12|63|101|3527	PF00001;PF00041;PF00079;PF00084;PF00129;PF00320;PF07679;PF07686;PF07714;PF13306;PF13895;PF13927
Group	GO:0008283	cell proliferation	2	7.30	1.39e-07	8.41e-07	14|63|145|3527	PF00001;PF00041;PF00046;PF00530;PF00870;PF00907;PF01153;PF07679;PF07686;PF07710;PF07714;PF10409;PF13465;PF13895
Group	GO:0001568	blood vessel development	2	7.67	1.56e-07	9.34e-07	12|63|103|3527	PF00001;PF00046;PF00090;PF00530;PF00907;PF01833;PF07645;PF07679;PF07686;PF07714;PF13465;PF13895
Group	GO:0034330	cell junction organization	2	8.20	1.78e-07	1.04e-06	10|63|67|3527	PF00028;PF00041;PF00071;PF00135;PF01049;PF07645;PF07679;PF07686;PF07714;PF13895
Group	GO:0001763	morphogenesis of a branching structure	2	8.12	2.05e-07	1.17e-06	10|63|68|3527	PF00001;PF00046;PF00090;PF00413;PF00870;PF01833;PF07645;PF07679;PF07714;PF13465
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	7.80	2.08e-07	1.17e-06	11|63|86|3527	PF00041;PF00071;PF00613;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0021700	developmental maturation	2	7.97	2.72e-07	1.49e-06	10|63|70|3527	PF00028;PF00041;PF00060;PF00071;PF00520;PF01094;PF01833;PF07679;PF13895;PF13927
Group	GO:0043069	negative regulation of programmed cell death	2	7.34	3.26e-07	1.75e-06	12|63|110|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00320;PF00520;PF00613;PF01094;PF07714;PF13895;PF13927
Group	GO:0035239	tube morphogenesis	2	7.34	3.26e-07	1.75e-06	12|63|110|3527	PF00001;PF00046;PF00090;PF00320;PF00413;PF00520;PF00870;PF00907;PF07679;PF07686;PF07714;PF13465
Group	GO:0006952	defense response	2	6.78	3.54e-07	1.87e-06	15|63|181|3527	PF00001;PF00041;PF00071;PF00079;PF00084;PF00129;PF00969;PF01094;PF07654;PF07686;PF07714;PF10409;PF13306;PF13895;PF13927
Group	GO:0046903	secretion	2	7.29	3.61e-07	1.89e-06	12|63|111|3527	PF00001;PF00041;PF00046;PF00071;PF00520;PF00683;PF02931;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	8.05	4.73e-07	2.25e-06	9|63|57|3527	PF00028;PF00041;PF00046;PF01153;PF05923;PF07679;PF07714;PF09422;PF13895
Group	GO:0060627	regulation of vesicle-mediated transport	2	8.05	4.73e-07	2.25e-06	9|63|57|3527	PF00001;PF00071;PF00520;PF01833;PF07645;PF07686;PF07714;PF13465;PF13895
Group	GO:0007552	metamorphosis	2	7.70	4.67e-07	2.25e-06	10|63|74|3527	PF00046;PF00135;PF00413;PF01833;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465
Group	GO:0003002	regionalization	2	6.98	4.71e-07	2.25e-06	13|63|136|3527	PF00028;PF00041;PF00046;PF00135;PF00320;PF00870;PF01153;PF05110;PF05923;PF07679;PF07710;PF07714;PF13465
Group	GO:0008284	positive regulation of cell proliferation	2	7.16	4.85e-07	2.28e-06	12|63|114|3527	PF00001;PF00041;PF00046;PF00320;PF00870;PF00907;PF00930;PF07679;PF07686;PF07714;PF13465;PF13895
Group	GO:0002165	instar larval or pupal development	2	7.26	1.11e-06	4.97e-06	10|63|81|3527	PF00046;PF00135;PF00413;PF01833;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	7.56	1.14e-06	5.02e-06	9|63|63|3527	PF00041;PF00060;PF00520;PF01094;PF01833;PF02931;PF07679;PF13895;PF13927
Group	GO:0045165	cell fate commitment	2	6.92	1.34e-06	5.78e-06	11|63|103|3527	PF00046;PF00320;PF00870;PF00907;PF07645;PF07679;PF07714;PF10409;PF13465;PF13895;PF13927
Group	GO:0051130	positive regulation of cellular component organization	2	6.87	1.48e-06	6.26e-06	11|63|104|3527	PF00001;PF00041;PF00046;PF00071;PF00135;PF00870;PF07679;PF07686;PF07710;PF07714;PF13895
Group	GO:0032535	regulation of cellular component size	2	7.41	1.50e-06	6.27e-06	9|63|65|3527	PF00041;PF00046;PF00071;PF05110;PF07679;PF07714;PF10409;PF13895;PF13927
Group	GO:0010817	regulation of hormone levels	2	7.41	1.50e-06	6.27e-06	9|63|65|3527	PF00001;PF00046;PF00201;PF00520;PF00683;PF00685;PF00743;PF03098;PF07645
Group	GO:0042060	wound healing	2	7.03	1.74e-06	7.22e-06	10|63|85|3527	PF00001;PF00041;PF00071;PF00084;PF00320;PF00520;PF03508;PF07679;PF07686;PF07714
Group	GO:0009886	post-embryonic morphogenesis	2	6.87	2.41e-06	9.72e-06	10|63|88|3527	PF00046;PF00135;PF00413;PF01833;PF07645;PF07679;PF07686;PF07714;PF10409;PF13465
Group	GO:0030855	epithelial cell differentiation	2	7.13	2.52e-06	1.00e-05	9|63|69|3527	PF00041;PF00135;PF00320;PF00870;PF07645;PF07679;PF07714;PF13465;PF13895
Group	GO:0048569	post-embryonic organ development	2	6.71	3.30e-06	1.24e-05	10|63|91|3527	PF00046;PF00135;PF00413;PF01833;PF07645;PF07679;PF07686;PF07714;PF13465;PF13895
Group	GO:0051050	positive regulation of transport	2	6.62	4.03e-06	1.50e-05	10|63|93|3527	PF00001;PF00046;PF00071;PF00320;PF00969;PF01094;PF07654;PF07686;PF07714;PF13895
Group	GO:0032970	regulation of actin filament-based process	2	7.20	4.14e-06	1.52e-05	8|63|55|3527	PF00001;PF00041;PF00046;PF00071;PF07686;PF07714;PF13895;PF13927
Group	GO:0035107	appendage morphogenesis	2	6.57	4.45e-06	1.60e-05	10|63|94|3527	PF00046;PF00135;PF00870;PF00907;PF01153;PF01833;PF07645;PF07679;PF07714;PF13465
Group	GO:0050890	cognition	2	6.96	6.25e-06	2.11e-05	8|63|58|3527	PF00060;PF00071;PF00135;PF00520;PF00530;PF01094;PF02931;PF07714
Group	GO:0051347	positive regulation of transferase activity	2	6.63	6.41e-06	2.15e-05	9|63|77|3527	PF00001;PF00041;PF00071;PF02931;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0050808	synapse organization	2	7.22	8.04e-06	2.66e-05	7|63|43|3527	PF00001;PF00028;PF00135;PF00520;PF07679;PF07714;PF08266
Group	GO:0008360	regulation of cell shape	2	6.74	9.21e-06	3.00e-05	8|63|61|3527	PF00071;PF05902;PF07679;PF07686;PF07714;PF10409;PF13895;PF13927
Group	GO:0048732	gland development	2	6.41	9.81e-06	3.18e-05	9|63|81|3527	PF00041;PF00046;PF00870;PF00907;PF07679;PF07686;PF07714;PF10409;PF13465
Group	GO:0001817	regulation of cytokine production	2	6.36	1.09e-05	3.45e-05	9|63|82|3527	PF00001;PF00320;PF00969;PF02931;PF07654;PF07686;PF13465;PF13895;PF13927
Group	GO:0030198	extracellular matrix organization	2	6.60	1.18e-05	3.65e-05	8|63|63|3527	PF00041;PF00079;PF00090;PF00413;PF00530;PF01421;PF07679;PF13895
Group	GO:0044087	regulation of cellular component biogenesis	2	6.08	1.22e-05	3.75e-05	10|63|105|3527	PF00001;PF00041;PF00046;PF00060;PF00071;PF00135;PF01094;PF07714;PF10409;PF13465
Group	GO:0051272	positive regulation of cellular component movement	2	6.83	1.48e-05	4.45e-05	7|63|47|3527	PF00001;PF00084;PF00090;PF00320;PF07714;PF13895;PF13927
Group	GO:0045765	regulation of angiogenesis	2	6.74	1.71e-05	5.07e-05	7|63|48|3527	PF00001;PF00041;PF00071;PF00079;PF00084;PF00090;PF07645
Group	GO:0061326	renal tubule development	2	7.14	1.94e-05	5.45e-05	6|63|33|3527	PF00046;PF00907;PF07679;PF07686;PF07714;PF13465
Group	GO:0048638	regulation of developmental growth	2	6.21	2.34e-05	6.20e-05	8|63|69|3527	PF00046;PF00320;PF00907;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0048872	homeostasis of number of cells	2	6.48	2.58e-05	6.81e-05	7|63|51|3527	PF00001;PF00320;PF00613;PF02192;PF07714;PF13465;PF13927
Group	GO:0007422	peripheral nervous system development	2	6.89	2.76e-05	6.97e-05	6|63|35|3527	PF00041;PF00046;PF00135;PF01421;PF07679;PF13895
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	5.53	2.72e-05	6.97e-05	11|63|140|3527	PF00001;PF00041;PF00071;PF00870;PF02931;PF07645;PF07679;PF07710;PF07714;PF13895;PF13927
Group	GO:0001558	regulation of cell growth	2	6.09	2.89e-05	7.21e-05	8|63|71|3527	PF00041;PF00870;PF07679;PF07710;PF07714;PF10409;PF13895;PF13927
Group	GO:0048610	cellular process involved in reproduction	2	5.25	3.05e-05	7.57e-05	13|63|197|3527	PF00001;PF00028;PF00041;PF00071;PF00084;PF00135;PF00320;PF00870;PF02931;PF07679;PF07686;PF07714;PF13895
Group	GO:0010942	positive regulation of cell death	2	5.61	3.18e-05	7.86e-05	10|63|117|3527	PF00041;PF00046;PF00060;PF00090;PF00870;PF00907;PF01094;PF07679;PF07710;PF10409
Group	GO:0070848	response to growth factor stimulus	2	6.77	3.27e-05	8.04e-05	6|63|36|3527	PF00071;PF00320;PF07679;PF07686;PF07714;PF13895
Group	GO:0009725	response to hormone stimulus	2	5.44	3.32e-05	8.13e-05	11|63|143|3527	PF00001;PF00041;PF00046;PF00079;PF00201;PF00320;PF00413;PF00613;PF07714;PF10409;PF13465
Group	GO:0040017	positive regulation of locomotion	2	6.25	3.79e-05	9.22e-05	7|63|54|3527	PF00001;PF00090;PF00320;PF07679;PF07714;PF13895;PF13927
Group	GO:0031589	cell-substrate adhesion	2	6.66	3.85e-05	9.33e-05	6|63|37|3527	PF00041;PF07645;PF07686;PF07714;PF13895;PF13927
Group	GO:0008038	neuron recognition	2	7.25	4.07e-05	9.60e-05	5|63|23|3527	PF00041;PF07679;PF07714;PF13895;PF13927
Group	GO:0007268	synaptic transmission	2	5.36	4.04e-05	9.60e-05	11|63|146|3527	PF00001;PF00041;PF00060;PF00071;PF00135;PF00520;PF01007;PF01094;PF02931;PF07679;PF07714
Group	GO:0045786	negative regulation of cell cycle	2	6.10	4.82e-05	1.12e-04	7|63|56|3527	PF00320;PF00870;PF07645;PF07679;PF07710;PF07714;PF10409
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	5.57	5.06e-05	1.17e-04	9|63|99|3527	PF00001;PF00041;PF00071;PF02931;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0021551	central nervous system morphogenesis	2	9.83	5.30e-05	1.20e-04	3|63|5|3527	PF00041;PF07679;PF13895
Group	GO:0030031	cell projection assembly	2	6.03	5.42e-05	1.21e-04	7|63|57|3527	PF00028;PF00041;PF00071;PF01833;PF07714;PF13895;PF13927
Group	GO:0008015	blood circulation	2	6.03	5.42e-05	1.21e-04	7|63|57|3527	PF00001;PF00041;PF00079;PF00520;PF01094;PF03098;PF07679
Group	GO:0007283	spermatogenesis	2	5.71	5.77e-05	1.27e-04	8|63|78|3527	PF00041;PF00320;PF01421;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0018193	peptidyl-amino acid modification	2	5.16	6.24e-05	1.35e-04	11|63|153|3527	PF00001;PF00041;PF00071;PF00535;PF00777;PF07645;PF07679;PF07714;PF12157;PF13895;PF13927
Group	GO:0043279	response to alkaloid	2	6.74	7.63e-05	1.64e-04	5|63|26|3527	PF00001;PF00060;PF00520;PF01094;PF02931
Group	GO:0030001	metal ion transport	2	5.18	7.92e-05	1.69e-04	10|63|130|3527	PF00001;PF00041;PF00046;PF00060;PF00520;PF01007;PF01094;PF01833;PF02931;PF07686
Group	GO:0016319	mushroom body development	2	7.58	8.10e-05	1.70e-04	4|63|14|3527	PF00041;PF07679;PF13895;PF13927
Group	GO:0014070	response to organic cyclic compound	2	6.15	8.10e-05	1.70e-04	6|63|42|3527	PF00001;PF00060;PF00201;PF00520;PF01094;PF02931
Group	GO:0007519	skeletal muscle tissue development	2	5.76	8.45e-05	1.76e-04	7|63|61|3527	PF00001;PF00041;PF00520;PF07679;PF07686;PF07714;PF13895
Group	GO:0060173	limb development	2	6.06	9.28e-05	1.91e-04	6|63|43|3527	PF00046;PF00870;PF00907;PF07679;PF07714;PF13465
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	6.06	9.28e-05	1.91e-04	6|63|43|3527	PF00046;PF00090;PF00683;PF00870;PF07645;PF13465
Group	GO:0023061	signal release	2	5.70	9.40e-05	1.93e-04	7|63|62|3527	PF00001;PF00046;PF00071;PF00520;PF00683;PF07645;PF07714
Group	GO:0030155	regulation of cell adhesion	2	5.42	9.87e-05	2.02e-04	8|63|84|3527	PF00041;PF01421;PF07645;PF07679;PF07714;PF10409;PF13465;PF13895
Group	GO:0016331	morphogenesis of embryonic epithelium	2	5.58	1.15e-04	2.29e-04	7|63|64|3527	PF00046;PF00071;PF00320;PF00870;PF07679;PF07714;PF13465
Group	GO:0060249	anatomical structure homeostasis	2	5.24	1.38e-04	2.69e-04	8|63|88|3527	PF00001;PF00041;PF00046;PF07679;PF07686;PF07714;PF13465;PF13895
Group	GO:0048705	skeletal system morphogenesis	2	5.72	1.55e-04	2.98e-04	6|63|47|3527	PF00046;PF00907;PF07645;PF07679;PF07714;PF13895
Group	GO:0019216	regulation of lipid metabolic process	2	5.40	1.55e-04	2.98e-04	7|63|67|3527	PF00001;PF00041;PF00071;PF07679;PF07714;PF13465;PF13895
Group	GO:0031532	actin cytoskeleton reorganization	2	6.78	1.85e-04	3.41e-04	4|63|17|3527	PF07686;PF07714;PF13895;PF13927
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	5.29	1.87e-04	3.42e-04	7|63|69|3527	PF00001;PF00041;PF00071;PF01833;PF07679;PF07714;PF13465
Group	GO:0072511	divalent inorganic cation transport	2	5.29	1.87e-04	3.42e-04	7|63|69|3527	PF00001;PF00041;PF00060;PF00520;PF01094;PF01833;PF02931
Group	GO:0055065	metal ion homeostasis	2	5.07	1.88e-04	3.44e-04	8|63|92|3527	PF00001;PF00041;PF00060;PF00520;PF00530;PF01094;PF02931;PF07714
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	4.66	1.91e-04	3.46e-04	11|63|173|3527	PF00046;PF00320;PF00870;PF00907;PF01833;PF07645;PF07679;PF07710;PF07714;PF12157;PF13465
Group	GO:0016358	dendrite development	2	5.57	1.96e-04	3.55e-04	6|63|49|3527	PF00041;PF00046;PF00520;PF07679;PF07714;PF13465
Group	GO:0045596	negative regulation of cell differentiation	2	4.87	2.00e-04	3.61e-04	9|63|118|3527	PF00046;PF00071;PF00320;PF00870;PF00907;PF07645;PF07679;PF13465;PF13895
Group	GO:0072507	divalent inorganic cation homeostasis	2	5.14	2.45e-04	4.32e-04	7|63|72|3527	PF00001;PF00041;PF00060;PF00520;PF01094;PF02931;PF07714
Group	GO:0001822	kidney development	2	5.09	2.67e-04	4.70e-04	7|63|73|3527	PF00041;PF00046;PF00320;PF07679;PF07714;PF13465;PF13895
Group	GO:0007512	adult heart development	2	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00001;PF00041;PF07679
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	5.04	2.91e-04	4.99e-04	7|63|74|3527	PF00001;PF00041;PF00320;PF07679;PF07714;PF13895;PF13927
Group	GO:0007346	regulation of mitotic cell cycle	2	4.76	3.36e-04	5.69e-04	8|63|100|3527	PF00046;PF00320;PF00870;PF07679;PF07686;PF07710;PF07714;PF13895
Group	GO:0003151	outflow tract morphogenesis	2	6.17	3.62e-04	6.03e-04	4|63|20|3527	PF00520;PF00907;PF07679;PF07714
Group	GO:0072657	protein localization to membrane	2	5.41	4.35e-04	6.94e-04	5|63|37|3527	PF00071;PF00135;PF00520;PF07679;PF07714
Group	GO:0007411	axon guidance	2	4.76	4.72e-04	7.43e-04	7|63|80|3527	PF00041;PF00046;PF01833;PF07645;PF07679;PF07714;PF13895
Group	GO:0032880	regulation of protein localization	2	4.76	4.72e-04	7.43e-04	7|63|80|3527	PF00001;PF00071;PF00320;PF00969;PF07654;PF07686;PF13927
Group	GO:0007568	aging	2	4.96	5.00e-04	7.86e-04	6|63|58|3527	PF00135;PF00520;PF00613;PF00870;PF00907;PF07710
Group	GO:0043549	regulation of kinase activity	2	4.37	5.50e-04	8.57e-04	9|63|135|3527	PF00001;PF00041;PF00071;PF02931;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0060560	developmental growth involved in morphogenesis	2	4.84	6.02e-04	9.03e-04	6|63|60|3527	PF00041;PF00071;PF07679;PF07714;PF13465;PF13895
Group	GO:0043408	regulation of MAPK cascade	2	4.58	6.36e-04	9.46e-04	7|63|84|3527	PF00001;PF00071;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:2000027	regulation of organ morphogenesis	2	4.79	6.58e-04	9.76e-04	6|63|61|3527	PF00001;PF00046;PF00320;PF07679;PF07714;PF13465
Group	GO:0048747	muscle fiber development	2	5.06	7.07e-04	1.05e-03	5|63|41|3527	PF00001;PF07679;PF07686;PF07714;PF13895
Group	GO:0007015	actin filament organization	2	4.68	7.83e-04	1.14e-03	6|63|63|3527	PF00001;PF00028;PF00046;PF00071;PF00613;PF10409
Group	GO:0034220	ion transmembrane transport	2	4.63	8.52e-04	1.22e-03	6|63|64|3527	PF00046;PF00060;PF00520;PF01007;PF01094;PF07686
Group	GO:0060348	bone development	2	4.90	8.84e-04	1.25e-03	5|63|43|3527	PF00520;PF07645;PF07679;PF07714;PF13895
Group	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2	4.90	8.84e-04	1.25e-03	5|63|43|3527	PF00046;PF00320;PF00683;PF00870;PF07645
Group	GO:0048863	stem cell differentiation	2	4.83	9.84e-04	1.39e-03	5|63|44|3527	PF00046;PF00071;PF07679;PF13465;PF13895
Group	GO:0006461	protein complex assembly	2	3.92	1.12e-03	1.57e-03	10|63|180|3527	PF00041;PF00125;PF00135;PF00520;PF00613;PF00969;PF07645;PF07654;PF07679;PF07714
Group	GO:0009416	response to light stimulus	2	4.05	1.28e-03	1.77e-03	8|63|122|3527	PF00001;PF00060;PF00201;PF00520;PF00870;PF01094;PF02931;PF07710
Group	GO:0009617	response to bacterium	2	4.16	1.33e-03	1.84e-03	7|63|95|3527	PF00001;PF00079;PF00084;PF00129;PF00969;PF07654;PF13895
Group	GO:0032844	regulation of homeostatic process	2	4.33	1.37e-03	1.85e-03	6|63|70|3527	PF00001;PF00041;PF00520;PF00969;PF07654;PF07714
Group	GO:0010564	regulation of cell cycle process	2	3.99	1.42e-03	1.91e-03	8|63|124|3527	PF00071;PF00320;PF00870;PF07679;PF07686;PF07710;PF07714;PF13895
Group	GO:0048562	embryonic organ morphogenesis	2	4.54	1.47e-03	1.97e-03	5|63|48|3527	PF00028;PF00046;PF00907;PF07679;PF07714
Group	GO:0048678	response to axon injury	2	5.34	2.12e-03	2.78e-03	3|63|15|3527	PF00041;PF07645;PF07679
Group	GO:0045892	negative regulation of transcription, DNA-dependent	2	3.78	2.12e-03	2.78e-03	8|63|132|3527	PF00046;PF00125;PF00530;PF00870;PF07679;PF07710;PF07714;PF13465
Group	GO:0016049	cell growth	2	4.18	2.50e-03	3.26e-03	5|63|54|3527	PF00041;PF00071;PF07679;PF07714;PF13895
Group	GO:0050678	regulation of epithelial cell proliferation	2	4.12	2.71e-03	3.47e-03	5|63|55|3527	PF00041;PF00046;PF00079;PF07679;PF07714
Group	GO:0001932	regulation of protein phosphorylation	2	3.56	2.72e-03	3.47e-03	9|63|169|3527	PF00001;PF00041;PF00071;PF02931;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0007369	gastrulation	2	4.07	2.94e-03	3.74e-03	5|63|56|3527	PF00001;PF00046;PF00320;PF00907;PF01049
Group	GO:0007498	mesoderm development	2	4.25	3.55e-03	4.46e-03	4|63|36|3527	PF00001;PF00046;PF00870;PF00907
Group	GO:0031099	regeneration	2	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF00041;PF03508;PF07645
Group	GO:0048737	imaginal disc-derived appendage development	2	3.91	3.69e-03	4.56e-03	5|63|59|3527	PF00046;PF00135;PF01833;PF07645;PF13465
Group	GO:0043269	regulation of ion transport	2	3.68	3.94e-03	4.85e-03	6|63|86|3527	PF00001;PF00135;PF00520;PF00930;PF13895;PF13927
Group	GO:0007186	G-protein coupled receptor signaling pathway	2	3.86	3.97e-03	4.87e-03	5|63|60|3527	PF00001;PF00520;PF01094;PF02191;PF02931
Group	GO:0051051	negative regulation of transport	2	3.86	3.97e-03	4.87e-03	5|63|60|3527	PF00001;PF01833;PF13465;PF13895;PF13927
Group	GO:0044092	negative regulation of molecular function	2	3.44	3.99e-03	4.88e-03	8|63|146|3527	PF00001;PF00028;PF00041;PF00046;PF00079;PF01094;PF08266;PF13895
Group	GO:0045893	positive regulation of transcription, DNA-dependent	2	3.40	4.34e-03	5.25e-03	8|63|148|3527	PF00046;PF00320;PF00870;PF00907;PF01833;PF07645;PF07714;PF12157
Group	GO:0009991	response to extracellular stimulus	2	3.49	4.38e-03	5.30e-03	7|63|117|3527	PF00071;PF00320;PF00520;PF00613;PF07714;PF10409;PF13465
Group	GO:0051345	positive regulation of hydrolase activity	2	3.38	6.42e-03	7.62e-03	6|63|95|3527	PF00001;PF00041;PF00870;PF07679;PF07714;PF13895
Group	GO:0051216	cartilage development	2	3.74	6.77e-03	7.98e-03	4|63|43|3527	PF00046;PF07645;PF07679;PF13895
Group	GO:0032409	regulation of transporter activity	2	3.68	7.35e-03	8.64e-03	4|63|44|3527	PF00001;PF00135;PF00520;PF13895
Group	GO:0044255	cellular lipid metabolic process	2	2.93	8.39e-03	9.77e-03	10|63|237|3527	PF00001;PF00046;PF00135;PF00201;PF00535;PF00613;PF00777;PF02192;PF03098;PF10409
Group	GO:0050777	negative regulation of immune response	3	15.10	3.84e-11	7.23e-10	8|63|15|3527	PF00041;PF00079;PF00084;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0050974	detection of mechanical stimulus involved in sensory perception	3	16.31	4.75e-11	8.34e-10	7|63|10|3527	PF00028;PF00520;PF01094;PF07679;PF07714;PF13895;PF13927
Group	GO:0031348	negative regulation of defense response	3	12.60	1.12e-09	1.29e-08	8|63|21|3527	PF00001;PF00041;PF00079;PF00320;PF07679;PF07714;PF13895;PF13927
Group	GO:0035162	embryonic hemopoiesis	3	14.71	2.06e-09	2.33e-08	6|63|9|3527	PF00071;PF00320;PF07679;PF07686;PF07714;PF13927
Group	GO:0048015	phosphatidylinositol-mediated signaling	3	12.29	6.98e-09	7.11e-08	7|63|17|3527	PF00001;PF00320;PF00613;PF07679;PF07714;PF13895;PF13927
Group	GO:0090130	tissue migration	3	12.10	3.97e-08	3.26e-07	6|63|13|3527	PF00001;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0018108	peptidyl-tyrosine phosphorylation	3	10.67	5.71e-08	4.47e-07	7|63|22|3527	PF00001;PF00041;PF07645;PF07679;PF07714;PF13895;PF13927
Group	GO:0060420	regulation of heart growth	3	11.62	6.85e-08	5.06e-07	6|63|14|3527	PF00320;PF00907;PF07679;PF07714;PF13465;PF13895
Group	GO:0043491	protein kinase B signaling cascade	3	11.62	6.85e-08	5.06e-07	6|63|14|3527	PF00041;PF00046;PF07679;PF10409;PF13895;PF13927
Group	GO:0051588	regulation of neurotransmitter transport	3	11.62	6.85e-08	5.06e-07	6|63|14|3527	PF00001;PF00071;PF00520;PF01094;PF01833;PF02931
Group	GO:0072148	epithelial cell fate commitment	3	14.84	9.25e-08	6.12e-07	4|63|4|3527	PF00320;PF07679;PF07714;PF13895
Group	GO:0038093	Fc receptor signaling pathway	3	14.84	9.25e-08	6.12e-07	4|63|4|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0038109	Kit signaling pathway	3	14.84	9.25e-08	6.12e-07	4|63|4|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0007419	ventral cord development	3	14.84	9.25e-08	6.12e-07	4|63|4|3527	PF07679;PF07686;PF07714;PF13895
Group	GO:0002440	production of molecular mediator of immune response	3	11.20	1.13e-07	7.26e-07	6|63|15|3527	PF00969;PF07654;PF07679;PF07714;PF13895;PF13927
Group	GO:0031341	regulation of cell killing	3	10.81	1.78e-07	1.04e-06	6|63|16|3527	PF00041;PF00129;PF07654;PF07686;PF13895;PF13927
Group	GO:0030540	female genitalia development	3	12.19	1.85e-07	1.07e-06	5|63|9|3527	PF00041;PF00046;PF00870;PF07714;PF13895
Group	GO:0030183	B cell differentiation	3	10.45	2.71e-07	1.49e-06	6|63|17|3527	PF00870;PF07679;PF07714;PF13465;PF13895;PF13927
Group	GO:0070664	negative regulation of leukocyte proliferation	3	11.53	3.64e-07	1.89e-06	5|63|10|3527	PF00969;PF07654;PF07686;PF13895;PF13927
Group	GO:0008589	regulation of smoothened signaling pathway	3	10.13	4.01e-07	2.04e-06	6|63|18|3527	PF00046;PF01153;PF07679;PF07714;PF13465;PF13895
Group	GO:0045161	neuronal ion channel clustering	3	13.21	4.57e-07	2.25e-06	4|63|5|3527	PF00041;PF07679;PF13895;PF13927
Group	GO:0038162	erythropoietin-mediated signaling pathway	3	13.21	4.57e-07	2.25e-06	4|63|5|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0090136	epithelial cell-cell adhesion	3	13.21	4.57e-07	2.25e-06	4|63|5|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0045471	response to ethanol	3	9.55	8.14e-07	3.70e-06	6|63|20|3527	PF00001;PF00060;PF00520;PF01094;PF02931;PF07714
Group	GO:0032102	negative regulation of response to external stimulus	3	9.55	8.14e-07	3.70e-06	6|63|20|3527	PF00001;PF00041;PF00060;PF00320;PF01094;PF07679
Group	GO:0001945	lymph vessel development	3	10.45	1.11e-06	4.97e-06	5|63|12|3527	PF00907;PF07645;PF07679;PF07714;PF13895
Group	GO:0014013	regulation of gliogenesis	3	9.29	1.12e-06	4.97e-06	6|63|21|3527	PF00001;PF00041;PF00046;PF07679;PF07714;PF13895
Group	GO:0045576	mast cell activation	3	12.01	1.35e-06	5.78e-06	4|63|6|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0030219	megakaryocyte differentiation	3	12.01	1.35e-06	5.78e-06	4|63|6|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0055024	regulation of cardiac muscle tissue development	3	10.00	1.79e-06	7.27e-06	5|63|13|3527	PF00320;PF00907;PF07679;PF07714;PF13895
Group	GO:0007520	myoblast fusion	3	10.00	1.79e-06	7.27e-06	5|63|13|3527	PF00041;PF00520;PF07679;PF07686;PF13895
Group	GO:0034332	adherens junction organization	3	9.60	2.74e-06	1.07e-05	5|63|14|3527	PF00028;PF01049;PF07679;PF07714;PF13895
Group	GO:0002695	negative regulation of leukocyte activation	3	9.60	2.74e-06	1.07e-05	5|63|14|3527	PF00969;PF07654;PF13465;PF13895;PF13927
Group	GO:0034109	homotypic cell-cell adhesion	3	11.07	3.11e-06	1.18e-05	4|63|7|3527	PF00041;PF07679;PF07714;PF13895
Group	GO:0043576	regulation of respiratory gaseous exchange	3	11.07	3.11e-06	1.18e-05	4|63|7|3527	PF00046;PF00060;PF00135;PF01094
Group	GO:0035112	genitalia morphogenesis	3	11.07	3.11e-06	1.18e-05	4|63|7|3527	PF00870;PF07679;PF07686;PF07714
Group	GO:0035215	genital disc development	3	11.07	3.11e-06	1.18e-05	4|63|7|3527	PF00046;PF07679;PF07686;PF07714
Group	GO:0061318	renal filtration cell differentiation	3	9.24	4.05e-06	1.50e-05	5|63|15|3527	PF00041;PF07679;PF07686;PF13465;PF13895
Group	GO:0021545	cranial nerve development	3	9.24	4.05e-06	1.50e-05	5|63|15|3527	PF00041;PF00046;PF00907;PF07714;PF13465
Group	GO:0001816	cytokine production	3	8.23	4.44e-06	1.60e-05	6|63|26|3527	PF00001;PF01833;PF07679;PF07714;PF13895;PF13927
Group	GO:0070983	dendrite guidance	3	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF00041;PF00046;PF07679
Group	GO:0035172	hemocyte proliferation	3	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF07679;PF07686;PF07714
Group	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	3	8.92	5.82e-06	1.99e-05	5|63|16|3527	PF00041;PF00071;PF07679;PF07714;PF13895
Group	GO:0030539	male genitalia development	3	10.31	6.14e-06	2.08e-05	4|63|8|3527	PF07679;PF07686;PF07714;PF13465
Group	GO:0042552	myelination	3	7.88	7.07e-06	2.35e-05	6|63|28|3527	PF00041;PF01421;PF07679;PF07714;PF13465;PF13895
Group	GO:0035176	social behavior	3	9.67	1.09e-05	3.45e-05	4|63|9|3527	PF00060;PF00135;PF00907;PF01094
Group	GO:0001964	startle response	3	9.67	1.09e-05	3.45e-05	4|63|9|3527	PF00028;PF00060;PF01094;PF02931
Group	GO:0038084	vascular endothelial growth factor signaling pathway	3	9.67	1.09e-05	3.45e-05	4|63|9|3527	PF07679;PF07686;PF07714;PF13895
Group	GO:0007224	smoothened signaling pathway	3	8.35	1.11e-05	3.47e-05	5|63|18|3527	PF00041;PF00046;PF07679;PF13465;PF13895
Group	GO:0050773	regulation of dendrite development	3	8.35	1.11e-05	3.47e-05	5|63|18|3527	PF00060;PF00135;PF01094;PF02931;PF10409
Group	GO:0042476	odontogenesis	3	8.09	1.49e-05	4.45e-05	5|63|19|3527	PF00870;PF00907;PF07679;PF07714;PF13465
Group	GO:0001657	ureteric bud development	3	8.09	1.49e-05	4.45e-05	5|63|19|3527	PF00046;PF00320;PF07679;PF07714;PF13465
Group	GO:0061039	ovum-producing ovary development	3	8.09	1.49e-05	4.45e-05	5|63|19|3527	PF01421;PF07679;PF07714;PF13895;PF13927
Group	GO:0001818	negative regulation of cytokine production	3	8.09	1.49e-05	4.45e-05	5|63|19|3527	PF00001;PF00969;PF02931;PF07654;PF13465
Group	GO:0007447	imaginal disc pattern formation	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00028;PF00041;PF00046;PF13465
Group	GO:0009954	proximal/distal pattern formation	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00046;PF00135;PF00870;PF13465
Group	GO:0071774	response to fibroblast growth factor stimulus	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00071;PF07679;PF07714;PF13895
Group	GO:0007442	hindgut morphogenesis	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF07679;PF07686;PF07714;PF13465
Group	GO:0034446	substrate adhesion-dependent cell spreading	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00041;PF07714;PF13895;PF13927
Group	GO:0060411	cardiac septum morphogenesis	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00907;PF07645;PF07679;PF07714
Group	GO:0035010	encapsulation of foreign target	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF00041;PF00071;PF07714;PF10409
Group	GO:0002444	myeloid leukocyte mediated immunity	3	9.14	1.79e-05	5.07e-05	4|63|10|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0045610	regulation of hemocyte differentiation	3	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF07679;PF07686;PF07714
Group	GO:0051231	spindle elongation	3	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF07679;PF07686;PF07714
Group	GO:0060462	lung lobe development	3	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF00320;PF07679;PF07714
Group	GO:0060484	lung-associated mesenchyme development	3	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF07679;PF07714;PF13895
Group	GO:0030032	lamellipodium assembly	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00041;PF07714;PF13895;PF13927
Group	GO:0035020	regulation of Rac protein signal transduction	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00041;PF00071;PF07679;PF07714
Group	GO:0006582	melanin metabolic process	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00041;PF00071;PF07714;PF10409
Group	GO:0045055	regulated secretory pathway	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0019233	sensory perception of pain	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00001;PF00060;PF01094;PF02931
Group	GO:0048645	organ formation	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00041;PF00870;PF07679;PF07714
Group	GO:0031294	lymphocyte costimulation	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00930;PF00969;PF07654;PF07686
Group	GO:0035264	multicellular organism growth	3	8.67	2.78e-05	6.97e-05	4|63|11|3527	PF00028;PF00870;PF07679;PF07714
Group	GO:0046634	regulation of alpha-beta T cell activation	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF00001;PF07654;PF07714;PF13465
Group	GO:0090102	cochlea development	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF00907;PF07679;PF07714;PF13895
Group	GO:0007298	border follicle cell migration	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF00071;PF07679;PF07686;PF07714
Group	GO:0072012	glomerulus vasculature development	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF07679;PF07714;PF13465;PF13895
Group	GO:0002275	myeloid cell activation involved in immune response	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0046887	positive regulation of hormone secretion	3	8.26	4.11e-05	9.60e-05	4|63|12|3527	PF00001;PF00046;PF00969;PF07654
Group	GO:0002699	positive regulation of immune effector process	3	7.07	5.07e-05	1.17e-04	5|63|24|3527	PF00129;PF07654;PF07686;PF07714;PF13895
Group	GO:0002067	glandular epithelial cell differentiation	3	9.83	5.30e-05	1.20e-04	3|63|5|3527	PF00870;PF07679;PF07714
Group	GO:0060384	innervation	3	9.83	5.30e-05	1.20e-04	3|63|5|3527	PF07679;PF07714;PF13895
Group	GO:0048036	central complex development	3	9.83	5.30e-05	1.20e-04	3|63|5|3527	PF00041;PF07679;PF13895
Group	GO:0032350	regulation of hormone metabolic process	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF00079;PF00320;PF00520;PF13465
Group	GO:0050852	T cell receptor signaling pathway	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF00041;PF00320;PF00969;PF07654
Group	GO:0030177	positive regulation of Wnt receptor signaling pathway	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF01153;PF07679;PF07714;PF13895
Group	GO:0002573	myeloid leukocyte differentiation	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF07679;PF07714;PF13895;PF13927
Group	GO:0072002	Malpighian tubule development	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF00907;PF07679;PF07686;PF07714
Group	GO:0051952	regulation of amine transport	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF00001;PF00520;PF01094;PF02931
Group	GO:0048483	autonomic nervous system development	3	7.90	5.86e-05	1.27e-04	4|63|13|3527	PF00046;PF00320;PF00870;PF00907
Group	GO:0033555	multicellular organismal response to stress	3	7.58	8.10e-05	1.70e-04	4|63|14|3527	PF00001;PF00060;PF00520;PF01094
Group	GO:1901216	positive regulation of neuron death	3	7.58	8.10e-05	1.70e-04	4|63|14|3527	PF00041;PF00870;PF07679;PF07710
Group	GO:0072210	metanephric nephron development	3	7.58	8.10e-05	1.70e-04	4|63|14|3527	PF07679;PF07714;PF13465;PF13895
Group	GO:0006954	inflammatory response	3	6.59	9.24e-05	1.91e-04	5|63|27|3527	PF00001;PF00969;PF07654;PF07714;PF13895
Group	GO:0060037	pharyngeal system development	3	8.92	1.05e-04	2.10e-04	3|63|6|3527	PF00046;PF00320;PF00907
Group	GO:0060442	branching involved in prostate gland morphogenesis	3	8.92	1.05e-04	2.10e-04	3|63|6|3527	PF00046;PF07679;PF07714
Group	GO:0010002	cardioblast differentiation	3	8.92	1.05e-04	2.10e-04	3|63|6|3527	PF07679;PF13465;PF13895
Group	GO:0038007	netrin-activated signaling pathway	3	8.92	1.05e-04	2.10e-04	3|63|6|3527	PF00041;PF00090;PF07679
Group	GO:0045621	positive regulation of lymphocyte differentiation	3	7.29	1.09e-04	2.17e-04	4|63|15|3527	PF00041;PF00320;PF07714;PF13465
Group	GO:0019884	antigen processing and presentation of exogenous antigen	3	7.29	1.09e-04	2.17e-04	4|63|15|3527	PF00129;PF00969;PF07654;PF13895
Group	GO:0045834	positive regulation of lipid metabolic process	3	6.31	1.32e-04	2.61e-04	5|63|29|3527	PF00041;PF00071;PF07679;PF07714;PF13895
Group	GO:0002088	lens development in camera-type eye	3	7.03	1.43e-04	2.78e-04	4|63|16|3527	PF00046;PF07679;PF07714;PF13895
Group	GO:0021510	spinal cord development	3	7.03	1.43e-04	2.78e-04	4|63|16|3527	PF00046;PF00520;PF07645;PF13465
Group	GO:0007585	respiratory gaseous exchange	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00060;PF00071;PF01094
Group	GO:0021548	pons development	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00060;PF00520;PF01094
Group	GO:0060525	prostate glandular acinus development	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00870;PF07679;PF07714
Group	GO:0060443	mammary gland morphogenesis	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00907;PF07679;PF07714
Group	GO:0070050	neuron homeostasis	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00041;PF07679;PF07714
Group	GO:0021578	hindbrain maturation	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00060;PF00520;PF01094
Group	GO:0060039	pericardium development	3	8.21	1.81e-04	3.38e-04	3|63|7|3527	PF00907;PF07645;PF13465
Group	GO:0050707	regulation of cytokine secretion	3	6.78	1.85e-04	3.41e-04	4|63|17|3527	PF00001;PF00320;PF00969;PF07654
Group	GO:0048066	developmental pigmentation	3	6.78	1.85e-04	3.41e-04	4|63|17|3527	PF00071;PF07714;PF13895;PF13927
Group	GO:0014066	regulation of phosphatidylinositol 3-kinase cascade	3	6.78	1.85e-04	3.41e-04	4|63|17|3527	PF00001;PF07679;PF07714;PF13895
Group	GO:0090068	positive regulation of cell cycle process	3	5.94	2.15e-04	3.87e-04	5|63|32|3527	PF00071;PF00320;PF00870;PF07686;PF07710
Group	GO:0003231	cardiac ventricle development	3	6.56	2.35e-04	4.16e-04	4|63|18|3527	PF00320;PF07679;PF07714;PF13465
Group	GO:0007435	salivary gland morphogenesis	3	6.56	2.35e-04	4.16e-04	4|63|18|3527	PF07679;PF07686;PF07714;PF10409
Group	GO:0046425	regulation of JAK-STAT cascade	3	6.56	2.35e-04	4.16e-04	4|63|18|3527	PF00041;PF07714;PF13465;PF13927
Group	GO:0045580	regulation of T cell differentiation	3	6.56	2.35e-04	4.16e-04	4|63|18|3527	PF00041;PF00320;PF07714;PF13465
Group	GO:0036058	filtration diaphragm assembly	3	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00041;PF07679;PF13895
Group	GO:0048644	muscle organ morphogenesis	3	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00907;PF07679;PF07714
Group	GO:0032673	regulation of interleukin-4 production	3	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00320;PF00969;PF07654
Group	GO:0010453	regulation of cell fate commitment	3	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00046;PF07679;PF07714
Group	GO:0034121	regulation of toll-like receptor signaling pathway	3	7.63	2.85e-04	4.93e-04	3|63|8|3527	PF00041;PF07679;PF07714
Group	GO:0060191	regulation of lipase activity	3	6.36	2.93e-04	4.99e-04	4|63|19|3527	PF00001;PF07679;PF07714;PF13895
Group	GO:0021536	diencephalon development	3	6.36	2.93e-04	4.99e-04	4|63|19|3527	PF00046;PF07679;PF07714;PF13895
Group	GO:0009636	response to toxin	3	6.36	2.93e-04	4.99e-04	4|63|19|3527	PF00060;PF00135;PF01094;PF02931
Group	GO:0006956	complement activation	3	6.17	3.62e-04	6.03e-04	4|63|20|3527	PF00084;PF00090;PF07645;PF07686
Group	GO:0071383	cellular response to steroid hormone stimulus	3	6.17	3.62e-04	6.03e-04	4|63|20|3527	PF00046;PF00201;PF07714;PF13465
Group	GO:0043277	apoptotic cell clearance	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF07645;PF07714;PF13927
Group	GO:0001751	compound eye photoreceptor cell differentiation	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00071;PF05110;PF10409
Group	GO:0003401	axis elongation	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF07679;PF07714;PF13465
Group	GO:0050806	positive regulation of synaptic transmission	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00135;PF01094;PF07679
Group	GO:0007157	heterophilic cell-cell adhesion	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF07679;PF07686;PF13895
Group	GO:0008354	germ cell migration	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00001;PF07686;PF13895
Group	GO:0060004	reflex	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00028;PF00520;PF02931
Group	GO:0007616	long-term memory	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00060;PF00530;PF01094
Group	GO:0043278	response to morphine	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00001;PF00060;PF01094
Group	GO:0060428	lung epithelium development	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF07679;PF07714;PF13895
Group	GO:0060571	morphogenesis of an epithelial fold	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00870;PF07679;PF07714
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF00028;PF01049;PF08266
Group	GO:0048286	lung alveolus development	3	7.15	4.23e-04	6.77e-04	3|63|9|3527	PF07679;PF07714;PF13895
Group	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3	5.99	4.41e-04	7.00e-04	4|63|21|3527	PF00041;PF07714;PF13895;PF13927
Group	GO:0007416	synapse assembly	3	5.82	5.31e-04	8.30e-04	4|63|22|3527	PF00028;PF00135;PF00520;PF08266
Group	GO:0007606	sensory perception of chemical stimulus	3	5.82	5.31e-04	8.30e-04	4|63|22|3527	PF00060;PF01094;PF07686;PF13895
Group	GO:0019730	antimicrobial humoral response	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00079;PF07679;PF07714
Group	GO:0090109	regulation of cell-substrate junction assembly	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00041;PF07714;PF10409
Group	GO:0060742	epithelial cell differentiation involved in prostate gland development	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00870;PF07679;PF07714
Group	GO:0051784	negative regulation of nuclear division	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF07679;PF07714;PF13895
Group	GO:0072102	glomerulus morphogenesis	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF07679;PF07714;PF13895
Group	GO:0001823	mesonephros development	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00046;PF00320;PF13465
Group	GO:0060425	lung morphogenesis	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00320;PF07679;PF07714
Group	GO:0035249	synaptic transmission, glutamatergic	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00060;PF00520;PF01094
Group	GO:0032649	regulation of interferon-gamma production	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00969;PF07654;PF13927
Group	GO:0030101	natural killer cell activation	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00041;PF13465;PF13927
Group	GO:0003179	heart valve morphogenesis	3	6.74	5.96e-04	8.98e-04	3|63|10|3527	PF00320;PF00907;PF07645
Group	GO:0060688	regulation of morphogenesis of a branching structure	3	5.67	6.35e-04	9.46e-04	4|63|23|3527	PF00001;PF00046;PF07679;PF07714
Group	GO:0016525	negative regulation of angiogenesis	3	5.67	6.35e-04	9.46e-04	4|63|23|3527	PF00041;PF00079;PF00090;PF07645
Group	GO:0007088	regulation of mitosis	3	5.52	7.51e-04	1.10e-03	4|63|24|3527	PF07679;PF07686;PF07714;PF13895
Group	GO:0050796	regulation of insulin secretion	3	5.52	7.51e-04	1.10e-03	4|63|24|3527	PF00520;PF00969;PF07654;PF13465
Group	GO:0001894	tissue homeostasis	3	5.52	7.51e-04	1.10e-03	4|63|24|3527	PF00001;PF00046;PF07686;PF13895
Group	GO:0007565	female pregnancy	3	5.52	7.51e-04	1.10e-03	4|63|24|3527	PF00001;PF00413;PF07686;PF13895
Group	GO:0048730	epidermis morphogenesis	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00870;PF07679;PF07714
Group	GO:0050805	negative regulation of synaptic transmission	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00001;PF00060;PF01094
Group	GO:0051898	negative regulation of protein kinase B signaling cascade	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00001;PF00041;PF10409
Group	GO:0007398	ectoderm development	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00046;PF09422;PF13465
Group	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00320;PF07679;PF07714
Group	GO:0031214	biomineral tissue development	3	6.39	8.09e-04	1.16e-03	3|63|11|3527	PF00907;PF07679;PF07714
Group	GO:0051048	negative regulation of secretion	3	5.38	8.83e-04	1.25e-03	4|63|25|3527	PF00001;PF01833;PF13465;PF13895
Group	GO:0042472	inner ear morphogenesis	3	5.25	1.03e-03	1.45e-03	4|63|26|3527	PF00028;PF00907;PF07679;PF07714
Group	GO:0034341	response to interferon-gamma	3	6.08	1.07e-03	1.49e-03	3|63|12|3527	PF00129;PF00969;PF07654
Group	GO:0002709	regulation of T cell mediated immunity	3	6.08	1.07e-03	1.49e-03	3|63|12|3527	PF00041;PF00129;PF07654
Group	GO:0002698	negative regulation of immune effector process	3	6.08	1.07e-03	1.49e-03	3|63|12|3527	PF00041;PF00084;PF13465
Group	GO:0048709	oligodendrocyte differentiation	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00046;PF07679;PF13895
Group	GO:0007179	transforming growth factor beta receptor signaling pathway	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00683;PF00870;PF07645
Group	GO:0050764	regulation of phagocytosis	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF07686;PF07714;PF13895
Group	GO:0033057	multicellular organismal reproductive behavior	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00060;PF00520;PF01094
Group	GO:0003073	regulation of systemic arterial blood pressure	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00001;PF00041;PF00079
Group	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors b	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00129;PF07654;PF13895
Group	GO:0009187	cyclic nucleotide metabolic process	3	5.81	1.37e-03	1.85e-03	3|63|13|3527	PF00001;PF01094;PF07714
Group	GO:0046777	protein autophosphorylation	3	5.01	1.37e-03	1.85e-03	4|63|28|3527	PF00041;PF07714;PF13895;PF13927
Group	GO:0010470	regulation of gastrulation	3	5.56	1.72e-03	2.28e-03	3|63|14|3527	PF00046;PF07714;PF13465
Group	GO:0060079	regulation of excitatory postsynaptic membrane potential	3	5.56	1.72e-03	2.28e-03	3|63|14|3527	PF00060;PF00135;PF01094
Group	GO:0042108	positive regulation of cytokine biosynthetic process	3	5.56	1.72e-03	2.28e-03	3|63|14|3527	PF07654;PF07686;PF13895
Group	GO:0002118	aggressive behavior	3	5.56	1.72e-03	2.28e-03	3|63|14|3527	PF13306;PF13895;PF13927
Group	GO:0051965	positive regulation of synapse assembly	3	5.34	2.12e-03	2.78e-03	3|63|15|3527	PF00041;PF00135;PF07714
Group	GO:0061035	regulation of cartilage development	3	5.34	2.12e-03	2.78e-03	3|63|15|3527	PF00530;PF07645;PF13465
Group	GO:0048520	positive regulation of behavior	3	5.34	2.12e-03	2.78e-03	3|63|15|3527	PF00001;PF00520;PF13895
Group	GO:0030901	midbrain development	3	5.34	2.12e-03	2.78e-03	3|63|15|3527	PF00046;PF07679;PF07714
Group	GO:0006937	regulation of muscle contraction	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00001;PF02931;PF07686
Group	GO:0035150	regulation of tube size	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00001;PF00079;PF00135
Group	GO:0048168	regulation of neuronal synaptic plasticity	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00060;PF00071;PF01094
Group	GO:0010464	regulation of mesenchymal cell proliferation	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00870;PF07679;PF07714
Group	GO:0051101	regulation of DNA binding	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00046;PF00320;PF07645
Group	GO:0043271	negative regulation of ion transport	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00001;PF13895;PF13927
Group	GO:1901185	negative regulation of ERBB signaling pathway	3	5.13	2.58e-03	3.30e-03	3|63|16|3527	PF00041;PF07679;PF13895
Group	GO:0050714	positive regulation of protein secretion	3	4.95	3.09e-03	3.90e-03	3|63|17|3527	PF00001;PF00320;PF07686
Group	GO:0016064	immunoglobulin mediated immune response	3	4.95	3.09e-03	3.90e-03	3|63|17|3527	PF00969;PF07654;PF07686
Group	GO:0030335	positive regulation of cell migration	3	4.25	3.55e-03	4.46e-03	4|63|36|3527	PF00001;PF00320;PF07714;PF13927
Group	GO:0022405	hair cycle process	3	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF00870;PF07679;PF07714
Group	GO:0001837	epithelial to mesenchymal transition	3	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF00530;PF01833;PF13465
Group	GO:2000242	negative regulation of reproductive process	3	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF00046;PF00079;PF13465
Group	GO:0007052	mitotic spindle organization	3	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF07679;PF07686;PF07714
Group	GO:0051302	regulation of cell division	3	4.78	3.66e-03	4.53e-03	3|63|18|3527	PF00071;PF07679;PF07714
Group	GO:0007050	cell cycle arrest	3	4.62	4.29e-03	5.21e-03	3|63|19|3527	PF00870;PF07645;PF07710
Group	GO:0044550	secondary metabolite biosynthetic process	3	4.62	4.29e-03	5.21e-03	3|63|19|3527	PF00071;PF00201;PF00743
Group	GO:0007569	cell aging	3	4.62	4.29e-03	5.21e-03	3|63|19|3527	PF00870;PF00907;PF07710
Group	GO:0001570	vasculogenesis	3	4.47	4.99e-03	5.97e-03	3|63|20|3527	PF00907;PF07645;PF07714
Group	GO:0030595	leukocyte chemotaxis	3	4.47	4.99e-03	5.97e-03	3|63|20|3527	PF00001;PF00041;PF07686
Group	GO:0007617	mating behavior	3	4.47	4.99e-03	5.97e-03	3|63|20|3527	PF00060;PF00520;PF01094
Group	GO:0018958	phenol-containing compound metabolic process	3	4.34	5.74e-03	6.83e-03	3|63|21|3527	PF00001;PF00320;PF03098
Group	GO:0061053	somite development	3	4.34	5.74e-03	6.83e-03	3|63|21|3527	PF00046;PF00870;PF00907
Group	GO:0007530	sex determination	3	4.34	5.74e-03	6.83e-03	3|63|21|3527	PF00041;PF07714;PF13465
Group	GO:0001892	embryonic placenta development	3	4.21	6.57e-03	7.75e-03	3|63|22|3527	PF07679;PF07714;PF13895
Group	GO:0060491	regulation of cell projection assembly	3	4.21	6.57e-03	7.75e-03	3|63|22|3527	PF00001;PF00071;PF07714
Group	GO:0030336	negative regulation of cell migration	3	4.09	7.46e-03	8.72e-03	3|63|23|3527	PF00001;PF00907;PF10409
Group	GO:0042157	lipoprotein metabolic process	3	4.09	7.46e-03	8.72e-03	3|63|23|3527	PF00535;PF07645;PF07714
Group	GO:0001666	response to hypoxia	3	3.62	7.96e-03	9.30e-03	4|63|45|3527	PF00413;PF00520;PF00530;PF02931
Group	GO:0045824	negative regulation of innate immune response	4	18.18	2.55e-11	5.65e-10	6|63|6|3527	PF00041;PF00079;PF07679;PF07714;PF13895;PF13927
Group	GO:0060911	cardiac cell fate commitment	4	14.84	9.25e-08	6.12e-07	4|63|4|3527	PF00046;PF00907;PF07679;PF13895
Group	GO:0060385	axonogenesis involved in innervation	4	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF07679;PF07714;PF13895
Group	GO:0061144	alveolar secondary septum development	4	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF07679;PF07714;PF13895
Group	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	4	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF00870;PF07679;PF07714
Group	GO:0021762	substantia nigra development	4	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF07679;PF07714;PF13895
Group	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	4	12.85	5.44e-06	1.87e-05	3|63|3|3527	PF07679;PF07714;PF13895
Group	GO:0060601	lateral sprouting from an epithelium	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF00870;PF07679;PF07714
Group	GO:2000352	negative regulation of endothelial cell apoptotic process	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF00320;PF07714;PF13895
Group	GO:0072277	metanephric glomerular capillary formation	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF07679;PF07714;PF13895
Group	GO:0034122	negative regulation of toll-like receptor signaling pathway	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF00041;PF07679;PF07714
Group	GO:0051150	regulation of smooth muscle cell differentiation	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF07679;PF07714;PF13465
Group	GO:0071205	protein localization to juxtaparanode region of axon	4	11.06	2.15e-05	5.72e-05	3|63|4|3527	PF00041;PF07679;PF13895
Group	GO:0031295	T cell costimulation	4	8.92	1.05e-04	2.10e-04	3|63|6|3527	PF00930;PF00969;PF07654
